These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23295051)

  • 1. Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.
    Efe C; Ozaslan E; Wahlin S; Purnak T; Muratori L; Quarneti C; Yüksel O; Muratori P
    Liver Int; 2013 Feb; 33(2):190-6. PubMed ID: 23295051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.
    Eyraud V; Chazouilleres O; Ballot E; Corpechot C; Poupon R; Johanet C
    Liver Int; 2009 Jul; 29(6):857-64. PubMed ID: 19302185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of anti-soluble liver antigen/liver-pancreas in diagnosing and typing autoimmune hepatitis].
    Zhao Y; Yan HP; Tan YF; Feng X; Liu Y; Cui D; Ma DM; Li WH; Zhang HP
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):283-6. PubMed ID: 17456317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
    Ma Y; Okamoto M; Thomas MG; Bogdanos DP; Lopes AR; Portmann B; Underhill J; Dürr R; Mieli-Vergani G; Vergani D
    Hepatology; 2002 Mar; 35(3):658-64. PubMed ID: 11870381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
    Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
    Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis.
    Zachou K; Gampeta S; Gatselis NK; Oikonomou K; Goulis J; Manoussakis MN; Renaudineau Y; Bogdanos DP; Dalekos GN
    Liver Int; 2015 Feb; 35(2):660-72. PubMed ID: 25113420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
    Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
    Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis.
    Vitozzi S; Djilali-Saiah I; Lapierre P; Alvarez F
    Autoimmunity; 2002 Dec; 35(8):485-92. PubMed ID: 12765473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis.
    Chen ZX; Shao JG; Shen Y; Zhang J; Hua Y; Wang LJ; Qin G
    Medicine (Baltimore); 2015 Jun; 94(23):e953. PubMed ID: 26061326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tRNP(ser)sec/SLA/LP autoantibodies. Comparative study using in-house ELISA with a recombinant 48.8 kDa protein, immunoblot, and analysis of immunoprecipitated RNAs.
    Torres-Collado AX; Czaja AJ; Gelpí C
    Liver Int; 2005 Apr; 25(2):410-9. PubMed ID: 15780067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay.
    Miyakawa H; Kawashima Y; Kitazawa E; Kawaguchi N; Kato T; Kikuchi K; Imai E; Fujikawa H; Hashimoto E; Schlumberger W
    J Autoimmun; 2003 Aug; 21(1):77-82. PubMed ID: 12892738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies and their antigens in autoimmune hepatitis.
    Bogdanos DP; Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and laboratory characteristics of anti-soluble liver antigen/liver-pancreas (SLA/LP) autoantibody positive liver disease patients].
    Liu YM; Yan HP; Tan YF; Liu Y; Feng X; Kong SL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):927-9. PubMed ID: 16381642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
    Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
    Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity to cytokeratin 8/18 in patients with soluble liver antigen (SLA) positive autoimmune hepatitis (AIH type 3) is not sufficient for diagnostic use.
    Martin L; Bäurle A; Fiehn W; Volkmann M
    Clin Lab; 2000; 46(7-8):339-44. PubMed ID: 10934580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
    Herkel J; Heidrich B; Nieraad N; Wies I; Rother M; Lohse AW
    Hepatology; 2002 Feb; 35(2):403-8. PubMed ID: 11826415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.
    Muratori P; Granito A; Pappas G; Pendino GM; Quarneti C; Cicola R; Menichella R; Ferri S; Cassani F; Bianchi FB; Lenzi M; Muratori L
    Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection.
    Vitozzi S; Lapierre P; Djilali-Saiah I; Marceau G; Beland K; Alvarez F
    Autoimmunity; 2004 May; 37(3):217-22. PubMed ID: 15497455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.